C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2009
12/31/2009	US20090325159 System and method to prevent cross-contamination in assays performed in a microfluidic channel
12/31/2009	US20090325158 5-Bromo-2'-Deoxy-Uridine Labeled Nucleotide Triphosphates and Nucleic Acid Probes and Methods of Making and Using the Same
12/31/2009	US20090325157 Pathogen detection and screening
12/31/2009	US20090325156 Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment
12/31/2009	US20090325155 Aureobasin a synthetase
12/31/2009	US20090325154 Pyrosequencing Methods and Related Compositions
12/31/2009	US20090325153 Analysis of heterogeneous nucleic acid samples
12/31/2009	US20090325152 Use of gene activity classifiers for the in vitro classification of gene expression profiles of patients with infectious/non-infectious multiple organ failure
12/31/2009	US20090325151 Pharmacogenomics of Blood Pressure Lowering Agents
12/31/2009	US20090325150 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
12/31/2009	US20090325149 Detection and distinguishing infections bursal disease virus (ibdv) strains by molecular biology method
12/31/2009	US20090325148 Bead Array Reader Based-Hemagglutination and Hemagglutination Inhibition Assay
12/31/2009	US20090325147 Molecularly imprinted polymers for detecting microorganisms
12/31/2009	US20090325146 Method of determining susceptibility of a tumor cell to a chemotherapeutic agent: novel use of herpes
12/31/2009	US20090325145 Methodology for analysis of sequence variations within the hcv ns5b genomic region
12/31/2009	US20090324730 Methods and compositions for the treatment of symptoms of complex regional pain syndrome
12/31/2009	US20090324646 Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression
12/31/2009	US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009	US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009	US20090324618 Novel signature self renewal gene expression programs
12/31/2009	US20090324617 Cancer specific glycans and use thereof
12/31/2009	US20090324616 Differential cytokine expression in human cancer
12/31/2009	US20090324615 Methods and compositions for modulating t cell and/or b cell activation
12/31/2009	US20090324610 Gene associated with arteriosclerotic disease, and use thereof
12/31/2009	US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof
12/31/2009	US20090324607 Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts
12/31/2009	US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009	US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders
12/31/2009	US20090324596 Methods of identifying and treating poor-prognosis cancers
12/31/2009	US20090324595 Cancer prognostic diagnostic and treatment methods
12/31/2009	US20090324593 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
12/31/2009	US20090324583 Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation
12/31/2009	US20090324582 Process for identification of molecular mimicry and the uses thereof
12/31/2009	US20090324580 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
12/31/2009	US20090324575 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
12/31/2009	US20090324572 Methods and compositions for the treatment of symptoms of williams syndrome
12/31/2009	US20090324559 Methods and platforms for drug discovery
12/31/2009	US20090324553 Chimeric Viral Envelopes
12/31/2009	US20090324550 Composition and method for inhibition of microorganisms
12/31/2009	US20090324546 Method for modulating gene expression by modifying the cpg content
12/31/2009	US20090324503 Methods for detecting a mycobacterium tuberculosis infection
12/31/2009	US20090324500 Screen for inflammatory response modulators
12/31/2009	US20090324498 Method of measuring quantity of in-vivo substance by use of coherent anti-stokes raman scattered light
12/31/2009	US20090324491 Diagnosis and Treatment of Cancer Using Anti-EREG Antibody
12/31/2009	US20090321281 Method of measuring blood component and sensor used in the method
12/31/2009	US20090321277 Electron-conducting crosslinked polyaniline-based redox hydrogel, and method of making
12/31/2009	US20090321259 Portable Preparation, Analysis, and Detection Apparatus for Nucleic Acid Processing
12/31/2009	DE102008029999A1 PCR-supported method for differential detection of physiological condition of cells comprises achieving the differentiation through the selection of suitable PCR primers for amplification of a section of a specific target sequence
12/31/2009	DE102007062847A1 Markersequenzen für neurodegenerative Erkrankungen und deren Verwendung Marker sequences for neurodegenerative diseases and their use
12/30/2009	WO2009158682A2 Compositions and methods for diagnosing and treating pathogenic disorders
12/30/2009	WO2009158620A2 Signatures and determinants associated with metastasis methods of use thereof
12/30/2009	WO2009158614A1 Novel astrovirus
12/30/2009	WO2009158606A2 Structure, synthesis, and applications for oligo phenylene ethynylenes
12/30/2009	WO2009158521A2 Blood transcriptional signature of mycobacterium tuberculosis infection
12/30/2009	WO2009158513A1 Gene expression profiling for identification, monitoring, and treatment of osteoarthritis
12/30/2009	WO2009158464A2 Thermoactive sivagm sab reverse transcriptase
12/30/2009	WO2009158451A1 Method and apparatus for melting curve analysis of nucleic acids in microarray format
12/30/2009	WO2009158143A1 Gene expression profiles to predict breast cancer outcomes
12/30/2009	WO2009158119A2 Compositions, kits and related methods for the detection and/or monitoring of salmonella
12/30/2009	WO2009158040A2 Cancer platinum resistance detection and sensitization method
12/30/2009	WO2009158035A2 Methods for dosing an activin-actriia antagonist and monitoring of treated patients
12/30/2009	WO2009158025A2 Methods for dosing an actriib antagonist and monitoring of treated patients
12/30/2009	WO2009158024A2 Microfluidic droplets for metabolic engineering and other applications
12/30/2009	WO2009158006A2 Methods and apparatus for detecting molecular interactions using fet arrays
12/30/2009	WO2009157750A1 A method for identifying a pork content in a food
12/30/2009	WO2009157683A2 Rt-pcr method using n-primer and kit for rt-pcr comprising n-primer
12/30/2009	WO2009157680A1 Nucleic acid extraction method
12/30/2009	WO2009157602A1 The recombinant chimeric protein for the diagnosis of taenia solium infection and diagnostic kits comprising the same toward a standardized serodiagnosis of taenia solium neurocysticercosis
12/30/2009	WO2009157510A1 Cartridge of microbial cell-capturing carrier, carrier treating device and method for counting microbial cells
12/30/2009	WO2009157465A1 Standard molecule for use in real-time pcr test, and detection of the standard molecule
12/30/2009	WO2009157452A1 Cyclic gmp detection method
12/30/2009	WO2009157353A1 Nucleic acid analyzer, automatic analyzer, and analysis method
12/30/2009	WO2009157327A1 Single molecule real time sequencer, nucleic acid analyzer and single molecule real time sequencing method
12/30/2009	WO2009157316A1 Diluting solution for suspension for use in the measurement of number of living microbial cells contained in sample, and method for measurement of number of living microbial cells
12/30/2009	WO2009157251A1 Method of diagnosing integration dysfunction syndrome
12/30/2009	WO2009157219A1 Method of electrochemically detecting nucleic acid with the use of dna conjugate
12/30/2009	WO2009157211A1 Method of measuring activity of cultured cells, microchamber, microchamber array, culture container and device for measuring activity of cultured cells
12/30/2009	WO2009157204A1 Diagnosis/therapeutic strategy for gynecological cancer by utilizing micro-rna as biomarker
12/30/2009	WO2009157000A1 TOMATO SlMYB12 TRANSCRIPTION FACTOR AND GENETIC SELECTION THEREOF
12/30/2009	WO2009156916A2 Melting curve measurement during amplification
12/30/2009	WO2009156915A1 Detection of tapped aliquots of amplified nucleic acids
12/30/2009	WO2009156895A1 Amplification of nucleic acids using temperature zones
12/30/2009	WO2009156858A1 Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen
12/30/2009	WO2009156741A1 Size standards for use in nucleic acid analysis
12/30/2009	WO2009156725A1 Characterising planar samples by mass spectrometry
12/30/2009	WO2009156688A2 New streptomyces beta-vulgaris strain, culture filtrate, derived active compounds and use thereof in the treatment of plants
12/30/2009	WO2009156687A2 New streptomyces barakatei strain, culture filtrate, derived active compounds and use thereof in the treatment of plants
12/30/2009	WO2009156584A1 Assessing risk of metastases and/or ddfs of patients with neoplasms, screening of patients responding to cancer therapy and such therapy
12/30/2009	WO2009156507A1 Prediction of antiviral therapy response
12/30/2009	WO2009156496A1 Plant improvement method
12/30/2009	WO2009156422A1 Novel mitochondrial dye
12/30/2009	WO2009156232A1 Method for characterising the biological activity of helminth eggs, in particular trichuris eggs
12/30/2009	WO2009156179A1 Her3 as a determinant for the prognosis of melanoma
12/30/2009	WO2009156162A2 Genome wide visual identification of human co-factors of hiv-1 infection
12/30/2009	WO2009156083A1 Novel variants of pqq-dependent glucose dehydrogenase having improved substrate specificity
12/30/2009	WO2009156030A1 Methods for producing inducible and/or repressible expression active linear rna interference cassettes and inducible and/or repressible expression active linear gene cassettes and their uses
12/30/2009	WO2009155961A1 Expression vectors based on modified ribosomal protein promoters and uses thereof in post-transcriptional assessment
12/30/2009	WO2009155950A1 Cloning-free method of generating transcriptionally and post-transcriptionally controllable expression active linear reporter constructs
12/30/2009	WO2009155772A1 Nucleic acid enrichment device and uses thereof
12/30/2009	WO2009155709A1 Bridged secondary amines and use thereof as iap bir domain binding compounds

1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 3003